GridAI Technologies (GRDX) EBT (2015 - 2025)
GridAI Technologies' (GRDX) quarterly EBT came in at -$4.0 million in Q4 2025, down 238.85% YoY from $2.9 million in Q4 2024, and down 316.76% on a QoQ basis from -$970856.0 in Q3 2025.
GridAI Technologies (GRDX) EBT (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of EBT data on file, last reported at -$4.0 million in Q4 2025.
- Quarterly EBT fell 238.85% year-over-year to -$4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.6 million (up 57.49% YoY) and the FY2025 annual result came in at -$6.6 million, up 57.49% from the prior year.
- EBT retreated to -$4.0 million in Q4 2025, from -$970856.0 in the prior quarter.
- In the past five years, EBT ranged from a high of $4.1 million in Q3 2022 to a low of -$30.9 million in Q3 2021.
- A 5-year average of -$5.6 million and a median of -$4.1 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2021 — EBT sank 482.0% — and 2022, when it surged 113.1%.
- Tracing GRDX's EBT over 5 years: stood at -$11.2 million in 2021, then soared by 79.58% to -$2.3 million in 2022, then sank by 79.85% to -$4.1 million in 2023, then surged by 70.9% to -$1.2 million in 2024, then plunged by 238.85% to -$4.0 million in 2025.
- The last three EBT figures came in at -$4.0 million (Q4 2025), -$970856.0 (Q3 2025), and -$674931.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | -4.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.05 Mn |
| Sep 30, 2025 | -970,856.00 |
| Jun 30, 2025 | -674,931.00 |
| Mar 31, 2025 | -948,105.00 |
| Dec 31, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | -3.43 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -4.10 Mn |
| Sep 30, 2023 | -3.43 Mn |
| Jun 30, 2023 | -4.19 Mn |
| Mar 31, 2023 | -4.07 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | 4.05 Mn |
| Jun 30, 2022 | -5.77 Mn |
| Mar 31, 2022 | -9.43 Mn |
| Dec 31, 2021 | -11.17 Mn |
| Sep 30, 2021 | -30.93 Mn |
| Jun 30, 2021 | -9.80 Mn |
| Mar 31, 2021 | -7.69 Mn |